<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399183</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2000-9666</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of community hospital internal medicine perspectives</Title><ISOAbbreviation>J Community Hosp Intern Med Perspect</ISOAbbreviation></Journal><ArticleTitle>Abnormal TSH Level as a Predictor of Severe Outcomes Among Patients Hospitalized With COVID-19.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>41</EndPage><MedlinePgn>35-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55729/2000-9666.1400</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess the association between thyroid dysfunction and mortality among patients hospitalized with COVID-19. Design: This is a retrospective multi-center study, which examined all patients admitted with Covid-19 diagnoses, and thyroid function results in absence of known thyroid disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">10,933 hospitalized COVID-19 positive patients were included in the study. These patients were without prior diagnosis or treatment of thyroid disease. Outcomes assessed were mortality, ICU admission, Ventilator use, length of stay, readmission and complications during hospital stay. Patients with low TSH and Low free T4 had odds of mortality of 10.07(95% CI [7.44-13.6]) compared to patients with Normal TSH and any free T4 levels. Patients with Low TSH and High free T4 also had odds of mortality of 1.38 (95% CI [1.19-1.59]) compared to patients with Normal TSH and Any free T4 level. Patients with Low TSH and Normal free T4 levels also had an Odds of mortality of 1.46 (95% CI [1.31-1.62]) compared to patients with Normal TSH and any free T4 level. Patients with Low TSH also had higher odds of ICU admission and Ventilator use when compared to patients with normal TSH.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study shows that patients with low TSH, regardless of free T4 level, indicates poor prognosis for hospitalized patients with SARS-CoV-2 infection and offers further insights into possible prognostic value of TSH levels for severe COVID-19 outcomes.</AbstractText><CopyrightInformation>© 2024 Greater Baltimore Medical Center.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Pinak A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Mountain View Hospital, Sunrise GME, Las Vegas, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shetty</LastName><ForeName>Kartika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mountain View Hospital, Sunrise GME, Las Vegas, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Faraz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mountain View Hospital, Sunrise GME, Las Vegas, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manov</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mountain View Hospital, Sunrise GME, Las Vegas, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharaf</LastName><ForeName>Mayesha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mountain View Hospital, Sunrise GME, Las Vegas, NV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Community Hosp Intern Med Perspect</MedlineTA><NlmUniqueID>101601396</NlmUniqueID><ISSNLinking>2000-9666</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Hospital outcomes</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">TSH</Keyword><Keyword MajorTopicYN="N">Thyroid dysfunction</Keyword></KeywordList><CoiStatement>Conflicts of interest: All authors have no financial disclosures or conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399183</ArticleId><ArticleId IdType="pmc">PMC11466342</ArticleId><ArticleId IdType="doi">10.55729/2000-9666.1400</ArticleId><ArticleId IdType="pii">jchim-14-05-035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Director-General’s opening remarks at the media briefing on COVID19. 2020 March;</Citation></Reference><Reference><Citation> [Accessed: March 31, 2023].  
 https://covid19.who.int/
</Citation></Reference><Reference><Citation> [Accessed: March 31, 2023].  
 https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions
.</Citation></Reference><Reference><Citation> [Accessed: March 31, 2023].  
 https://www.cdc.gov/nchs/covid19/nhcs/hospital-mortality-by-week.htm
.</Citation></Reference><Reference><Citation> [Accessed: March 31, 2023].  
 https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html
.</Citation></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011 Aug;21(8):879–890. doi: 10.1089/thy.2010.0429. . Epub 2011 Jul 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2010.0429</ArticleId><ArticleId IdType="pubmed">21745103</ArticleId></ArticleIdList></Reference><Reference><Citation>Duntas LH, Jonklaas J. COVID-19 and thyroid diseases: a bidirectional impact. J Endocr Soc. 2021 Apr 27;5(8):bvab076. doi: 10.1210/jendso/bvab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab076</ArticleId><ArticleId IdType="pmc">PMC8135350</ArticleId><ArticleId IdType="pubmed">34189381</ArticleId></ArticleIdList></Reference><Reference><Citation>Min Chen, Weibin Zhou, Weiwei Xu. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2021;31(1):8–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32600165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Cui Z, Shi N, et al. Suppression of the hypothalamic-pituitary- thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19. BMC Endocr Disord. 2021;21:228. doi: 10.1186/s12902-021-00896-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-021-00896-2</ArticleId><ArticleId IdType="pmc">PMC8591433</ArticleId><ArticleId IdType="pubmed">34781943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926–e935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania Andrea, et al. on behalf of Humanitas COVID-19 Task Force. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020 Oct;183(4):381–387. doi: 10.1530/EJE-20-0335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020 Sep;8(9):739–741. doi: 10.1016/S2213-8587(20)30266-7. . Epub 2020 Jul 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30266-7</ArticleId><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44:1031–1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605732</ArticleId><ArticleId IdType="pubmed">33140379</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvishi M, Nazer MR, Shahali H, Nouri M. Association of thyroid dysfunction and COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022 Oct 28;13:947594. doi: 10.3389/fendo.2022.947594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.947594</ArticleId><ArticleId IdType="pmc">PMC9650069</ArticleId><ArticleId IdType="pubmed">36387848</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotondi M, Coperchini F, Ricci G, et al. Detection of SARSCOV- 2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021 May;44(5):1085–1090. doi: 10.1007/s40618-020-01436-w. . Epub 2020 Oct 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01436-w</ArticleId><ArticleId IdType="pmc">PMC7538193</ArticleId><ArticleId IdType="pubmed">33025553</ArticleId></ArticleIdList></Reference><Reference><Citation>Croce L, Gangemi D, Ancona G, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest. 2021 May;44(5):891–904. doi: 10.1007/s40618-021-01506-7. . Epub 2021 Feb 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01506-7</ArticleId><ArticleId IdType="pmc">PMC7871522</ArticleId><ArticleId IdType="pubmed">33559848</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020 Jun;53:25–32. doi: 10.1016/j.cytogfr.2020.05.003. . Epub 2020 May 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti CL, Cazarin J, Hecht F, et al. COVID-19 and thyroid function: what do we know so far? Front Endocrinol (Lausanne) 2022 Dec 19;13:1041676. doi: 10.3389/fendo.2022.1041676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1041676</ArticleId><ArticleId IdType="pmc">PMC9806267</ArticleId><ArticleId IdType="pubmed">36601011</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014 Oct;24(10):1456–1465. doi: 10.1089/thy.2014.0201. . Epub 2014 Jun 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2014.0201</ArticleId><ArticleId IdType="pmc">PMC4195234</ArticleId><ArticleId IdType="pubmed">24845024</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura Neto A, Zantut-Wittmann DE. Abnormalities of thyroid hormone metabolism during systemic illness: the low T3 syndrome in different clinical settings. Int J Endocrinol. 2016;2016:2157583. doi: 10.1155/2016/2157583. . Epub 2016 Oct 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2157583</ArticleId><ArticleId IdType="pmc">PMC5075641</ArticleId><ArticleId IdType="pubmed">27803712</ArticleId></ArticleIdList></Reference><Reference><Citation>Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med. 1995 Dec 7;333(23):1562–1563. doi: 10.1056/NEJM199512073332310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199512073332310</ArticleId><ArticleId IdType="pubmed">7477174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015 Oct;3(10):816–825. doi: 10.1016/S2213-8587(15)00225-9. . Epub 2015 Jun 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00225-9</ArticleId><ArticleId IdType="pmc">PMC4979220</ArticleId><ArticleId IdType="pubmed">26071885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidart J, Jaskulski P, Kunzler AL, Marschner RA, Ferreira de Azeredo da Silva A, Wajner SM. Non-thyroidal illness syndrome predicts outcome in adult critically ill patients: a systematic review and meta-analysis. Endocr Connect. 2022 Feb 9;11(2):e210504. doi: 10.1530/EC-21-0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-0504</ArticleId><ArticleId IdType="pmc">PMC8859965</ArticleId><ArticleId IdType="pubmed">35015701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilber JF, Utiger RD. The effect of glucocorticoids on thyrotropin secretion. J Clin Invest. 1969 Nov;48(11):2096–2103. doi: 10.1172/JCI106176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI106176</ArticleId><ArticleId IdType="pmc">PMC297463</ArticleId><ArticleId IdType="pubmed">4980930</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011 Aug;21(8):879–890. doi: 10.1089/thy.2010.0429. . Epub 2011 Jul 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2010.0429</ArticleId><ArticleId IdType="pubmed">21745103</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek AH, Fliers E, Boelen A. Thyroid hormone metabolism in innate immune cells. J Endocrinol. 2017 Feb;232(2):R67–R81. doi: 10.1530/JOE-16-0462. . Epub 2016 Nov 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-16-0462</ArticleId><ArticleId IdType="pubmed">27852725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubingh J, van der Spek A, Fliers E, Boelen A. The role of thyroid hormone in the innate and adaptive immune response during infection. Compr Physiol. 2020 Sep 24;10(4):1277–1287. doi: 10.1002/cphy.c200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c200003</ArticleId><ArticleId IdType="pubmed">32969509</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>